592 related articles for article (PubMed ID: 25395390)
1. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study.
Jing J; Kielstein JT; Schultheiss UT; Sitter T; Titze SI; Schaeffner ES; McAdams-DeMarco M; Kronenberg F; Eckardt KU; Köttgen A;
Nephrol Dial Transplant; 2015 Apr; 30(4):613-21. PubMed ID: 25395390
[TBL] [Abstract][Full Text] [Related]
2. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.
Titze S; Schmid M; Köttgen A; Busch M; Floege J; Wanner C; Kronenberg F; Eckardt KU;
Nephrol Dial Transplant; 2015 Mar; 30(3):441-51. PubMed ID: 25271006
[TBL] [Abstract][Full Text] [Related]
3. Heart failure in a cohort of patients with chronic kidney disease: the GCKD study.
Beck H; Titze SI; Hübner S; Busch M; Schlieper G; Schultheiss UT; Wanner C; Kronenberg F; Krane V; Eckardt KU; Köttgen A;
PLoS One; 2015; 10(4):e0122552. PubMed ID: 25874373
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study.
Mohammed E; Browne LD; Kumar A U A; Adeeb F; Fraser AD; Stack AG
PLoS One; 2019; 14(1):e0210487. PubMed ID: 30682034
[TBL] [Abstract][Full Text] [Related]
5. The German Chronic Kidney Disease (GCKD) study: design and methods.
Eckardt KU; Bärthlein B; Baid-Agrawal S; Beck A; Busch M; Eitner F; Ekici AB; Floege J; Gefeller O; Haller H; Hilge R; Hilgers KF; Kielstein JT; Krane V; Köttgen A; Kronenberg F; Oefner P; Prokosch HU; Reis A; Schmid M; Schaeffner E; Schultheiss UT; Seuchter SA; Sitter T; Sommerer C; Walz G; Wanner C; Wolf G; Zeier M; Titze S
Nephrol Dial Transplant; 2012 Apr; 27(4):1454-60. PubMed ID: 21862458
[TBL] [Abstract][Full Text] [Related]
6. Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study.
Kielstein JT; Heisterkamp M; Jing J; Nadal J; Schmid M; Kronenberg F; Busch M; Sommerer C; Lorenzen JM; Eckardt KU; Köttgen A;
Clin Kidney J; 2021 Jan; 14(1):277-283. PubMed ID: 33564429
[TBL] [Abstract][Full Text] [Related]
7. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.
Schneider MP; Hilgers KF; Schmid M; Hübner S; Nadal J; Seitz D; Busch M; Haller H; Köttgen A; Kronenberg F; Baid-Agrawal S; Schlieper G; Schultheiss U; Sitter T; Sommerer C; Titze S; Meiselbach H; Wanner C; Eckardt KU;
PLoS One; 2018; 13(8):e0202604. PubMed ID: 30125326
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study.
Krishnan E
Arthritis Rheum; 2013 Dec; 65(12):3271-8. PubMed ID: 23982888
[TBL] [Abstract][Full Text] [Related]
10. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors.
Sánchez-Chaparro MA; Calvo-Bonacho E; González-Quintela A; Cabrera M; Quevedo-Aguado L; Fernández-Labandera C; Ruiz-Moraga M; Sainz-Gutiérrez JC; Gómez-Martínez P; Román-García J; Felices PV; Ruilope LM; Zanchetti A;
J Hypertens; 2014 Oct; 32(10):1970-8; discussion 1978. PubMed ID: 25023154
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
12. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.
Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
J Nephrol; 2021 Jun; 34(3):753-762. PubMed ID: 33439469
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
15. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients.
Arora P; Jalal K; Gupta A; Carter RL; Lohr JW
Int Urol Nephrol; 2017 Jun; 49(6):1033-1040. PubMed ID: 28236138
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation.
Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M
J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474
[TBL] [Abstract][Full Text] [Related]
17. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.
Roughley M; Sultan AA; Clarson L; Muller S; Whittle R; Belcher J; Mallen CD; Roddy E
Arthritis Res Ther; 2018 Oct; 20(1):243. PubMed ID: 30376864
[TBL] [Abstract][Full Text] [Related]
18. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
Miyakoshi T; Nakasone Y; Sato Y; Yamauchi K; Hashikura R; Takayama M; Hirabayashi K; Koike H; Moriya T; Aizawa T
Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
[TBL] [Abstract][Full Text] [Related]
19. Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
Kikuchi H; Kanda E; Mandai S; Akazawa M; Iimori S; Oi K; Naito S; Noda Y; Toda T; Tamura T; Sasaki S; Sohara E; Okado T; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):55-62. PubMed ID: 26920126
[TBL] [Abstract][Full Text] [Related]
20. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
